<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03345368</url>
  </required_header>
  <id_info>
    <org_study_id>211-010-01-17</org_study_id>
    <nct_id>NCT03345368</nct_id>
  </id_info>
  <brief_title>Effect of rTMS in Combination With a Low-carb Diet in Patients With Obesity</brief_title>
  <official_title>Effect of Repetitive Transcranial Magnetic Stimulation in Combination With a Low-carb Diet in Patients With Obesity: a Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Ajusco Medio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Ajusco Medio</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study the investigators want to evaluate if the application of rTMS can reduce
      the anxiety and craving in patients with obesity helping them to follow a low carb-diet, as
      well as, to assess the changes in weight, body mass index and quality of life before and
      after rTMS or sham rTMS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants completed a written, informed consent and rTMS adult safety questionnaire. The
      inclusion criteria are:

      individuals between 25 and 60 years of age with obesity in stage 1, 2 or 3. The exclusion
      criteria were: subjects with metabolic disorders, neurological condition, epilepsy, or
      pregnancy. The study conformed to the Declaration of Helsinki and was approved by the
      Institutional Medical Research Ethics Committee (Hospital Ajusco Medio, Mexico DF). The
      protocol will be applied as follows: 10 rTMS or sham sessions during two weeks. Following
      these two week, patients will receive 8 more sessions on weeks 4, 6, 8, 10, 12, 16, 20 and
      24. Diet will be indicated during all the protocol. The sham group will receive sham rTMS
      sessions for two weeks, the additional sessions will be performed in the same manner thar in
      rTMS group.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2017</start_date>
  <completion_date type="Anticipated">June 28, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 29, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Study participants will be randomly assigned to one of two groups: the experimental group receiving rTMS and a placebo group receiving sham rTMS. Both groups will be on the low-carb diet.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Sham rTMS will be administered with the coil held in contact with the head but at 180 degrees from scalp to avoid stimulation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Obesity, changes in the body mass index</measure>
    <time_frame>7 days</time_frame>
    <description>Obesity is a body mass index greater than or equal to 30.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obesity</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>rTMS treated group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A Magstim Rapid2 Stimulator equipped with a double 70mm alpha coil P/N 3191-00 (Magstim, Wales, UK) will be used to stimulate the motor cortex. Transcranial magnetic stimulation will be applied through a coil at 10 Hz, a field intensity of 90% of the motor threshold. Stimuli will be provided in 10 trains of 100 pulses, followed by a 28 s rest period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham rTMS group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham rTMS will be administered with the coil held in contact with the head but a 180 degrees from scalp, and the power parameter will be reduced by half to avoid stimulation.b</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <description>Patients will be stimulated in the dorso lateral frontal cortex. First, the motor threshold will be determined for each patient. To induce currents to the left primary sensory-motor cortex hand area (M1/S1) the coil will be placed over the scalp oriented at 45 ° from the mid-sagittal plane while subjects will sit comfortably on a chair. The coil will be systematically moved in this area until a contraction of the abductor will be identified. Motor evoked potentials (MEPs). MEPs will be registered with surface electrodes on the left hand abductor pollicis muscle using the same Magstim equipment. Then the parameters will be adjusted for the stimulation as was described before.</description>
    <arm_group_label>rTMS treated group</arm_group_label>
    <other_name>repetitive transcranial magnetic stimulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham rTMS</intervention_name>
    <description>As well as the rTMS group, the motor threshold of each patient will be determined. They will experience a similar rTMS session with the difference that they not will be stimulated.</description>
    <arm_group_label>sham rTMS group</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet</intervention_name>
    <description>This intervention will be applied to both groups, rTMS and sham group, as a combined therapy. The diet is low in carbohydrates, like sugary foods, pasta and bread. Instead, patients eat food with protein, natural fats and vegetables.</description>
    <arm_group_label>rTMS treated group</arm_group_label>
    <arm_group_label>sham rTMS group</arm_group_label>
    <other_name>conventional treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 30

        Exclusion Criteria:

          -  Thyroid problems, anorexia, bulimia, epilepsy, schizophrenia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Monica Ambriz-Tututi, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>HospitalGeneral Ajusco Medio</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monica Ambriz-Tututi, Dr.</last_name>
    <phone>+525551321200</phone>
    <phone_ext>7101</phone_ext>
    <email>qfbmonica@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beatriz Alvarado-Reynoso, MD</last_name>
    <phone>+525551321200</phone>
    <phone_ext>7101</phone_ext>
    <email>beatrizalvaradoreynoso@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital General Ajusco Medio</name>
      <address>
        <city>Mexico</city>
        <state>Tlalpan</state>
        <zip>14250</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beatriz Alvarado-Reynoso, MD</last_name>
      <phone>+525551321200</phone>
      <phone_ext>7101</phone_ext>
      <email>beatrizalvaradoreynoso@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Alonso-Alonso M, Pascual-Leone A. The right brain hypothesis for obesity. JAMA. 2007 Apr 25;297(16):1819-22.</citation>
    <PMID>17456824</PMID>
  </reference>
  <reference>
    <citation>Kober H, Mende-Siedlecki P, Kross EF, Weber J, Mischel W, Hart CL, Ochsner KN. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14811-6. doi: 10.1073/pnas.1007779107. Epub 2010 Aug 2.</citation>
    <PMID>20679212</PMID>
  </reference>
  <results_reference>
    <citation>Barth KS, Rydin-Gray S, Kose S, Borckardt JJ, O'Neil PM, Shaw D, Madan A, Budak A, George MS. Food cravings and the effects of left prefrontal repetitive transcranial magnetic stimulation using an improved sham condition. Front Psychiatry. 2011 Mar 14;2:9. doi: 10.3389/fpsyt.2011.00009. eCollection 2011.</citation>
    <PMID>21556279</PMID>
  </results_reference>
  <results_reference>
    <citation>Uher R, Yoganathan D, Mogg A, Eranti SV, Treasure J, Campbell IC, McLoughlin DM, Schmidt U. Effect of left prefrontal repetitive transcranial magnetic stimulation on food craving. Biol Psychiatry. 2005 Nov 15;58(10):840-2. Epub 2005 Aug 8.</citation>
    <PMID>16084855</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2017</study_first_submitted>
  <study_first_submitted_qc>November 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>April 9, 2018</last_update_submitted>
  <last_update_submitted_qc>April 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Ajusco Medio</investigator_affiliation>
    <investigator_full_name>Dra. Monica Ambriz Tututi</investigator_full_name>
    <investigator_title>Especialista en área de Salud</investigator_title>
  </responsible_party>
  <keyword>transcranial magnetic stimulation</keyword>
  <keyword>obesity</keyword>
  <keyword>diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

